In a transgenic murine model of GBM, the CXCL12-CXCR4 signaling pathway in neural progenitor tumor cells is activated under hypoxic conditions through an autocrine-positive feedback mechanism, which promotes survival and cell-cycle progression (14). The gene discussed is CXCL12; the disease is glioblastoma.